Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India
India contributed to one-fourth of the global burden of cervical cancer in 2000. [...]researchers emphasized the need for population-based interventions in India to reduce the overall burden of cervical cancer globally[3]. A multidisciplinary Expert Group constituted by the Secretary, Department of...
Gespeichert in:
| Veröffentlicht in: | Indian journal of medical research (New Delhi, India : 1994) India : 1994), 2017-08, Vol.146 (2), p.153-157 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 157 |
|---|---|
| container_issue | 2 |
| container_start_page | 153 |
| container_title | Indian journal of medical research (New Delhi, India : 1994) |
| container_volume | 146 |
| creator | Kaur, Prabhdeep Mehrotra, Ravi Rengaswamy, Sankaranarayanan Kaur, Tanvir Hariprasad, Roopa Mehendale, Sanjay M Rajaraman, Preetha Rath, G K Bhatla, Neerja Krishnan, Suneeta Nayyar, Anjali Swaminathan, Soumya |
| description | India contributed to one-fourth of the global burden of cervical cancer in 2000. [...]researchers emphasized the need for population-based interventions in India to reduce the overall burden of cervical cancer globally[3]. A multidisciplinary Expert Group constituted by the Secretary, Department of Health Research (DHR) and Director-General (DG), Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India, reviewed the available evidence globally regarding immunogenicity and efficacy, adverse effects and cost-effectiveness of the HPV vaccine. HPV infections, precancerous lesions and anogenital warts A systematic review of 20 studies from nine high-income countries analyzed the risk reduction in the HPV infection and anogenital warts in the vaccinated cohorts[9]. Protection is for only selected HPV types and does not cover all high-risk types. [...]comprehensive cervical cancer control also requires cervical cancer screening for early detection and treatment, even for those cohorts vaccinated against HPV. |
| doi_str_mv | 10.4103/ijmr.IJMR_1906_16 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5761024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A520292122</galeid><sourcerecordid>A520292122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c494t-b159d003a9bd1efcf00675fae05c8f0c43330088f7b02c5fbf6a49aa728ae06b3</originalsourceid><addsrcrecordid>eNptUU1v1DAQ9QFES-EHcEGWkLjtMnbiJOaAVFXQLipCquBsTRy7eBXbwd5E5d_j3X7QStiHkd689zQzj5A3DNY1g-qD2_q03nz9dqWYhEax5hk5BtmylZCsOSIvc94CMMlb-YIccckbAUwck3Qxewx0wsmNY_S4uDRnuqDWLhhqY6IagzalmLS4Gzols5iwczF8pFe4rzga-p4mo6P3JgwHLB-Uzk-jKdjugFEX6CYMDl-R5xbHbF7f1RPy88vnH2cXq8vv55uz08uVrmW9W_VMyAGgQtkPzFhtAZpWWDQgdGdB11VVAXSdbXvgWtjeNlhLxJZ3hdP01Qn5dOs7zb03gy6DJBzVlJzH9EdFdOppJ7hf6jouSrQNA14Xg3d3Bin-nk3eqW2cU1k4K85Fx1l57T_WdbmEcsHGYqa9y1qdCg7l1Izzwlr_h1X-YLzTMRjrCv5EwG4FOsWck7EPgzNQ-8TVPnH1OPGieft44wfFfdzVX0h3rP0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258211117</pqid></control><display><type>article</type><title>Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India</title><source>MEDLINE</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Kaur, Prabhdeep ; Mehrotra, Ravi ; Rengaswamy, Sankaranarayanan ; Kaur, Tanvir ; Hariprasad, Roopa ; Mehendale, Sanjay M ; Rajaraman, Preetha ; Rath, G K ; Bhatla, Neerja ; Krishnan, Suneeta ; Nayyar, Anjali ; Swaminathan, Soumya</creator><creatorcontrib>Kaur, Prabhdeep ; Mehrotra, Ravi ; Rengaswamy, Sankaranarayanan ; Kaur, Tanvir ; Hariprasad, Roopa ; Mehendale, Sanjay M ; Rajaraman, Preetha ; Rath, G K ; Bhatla, Neerja ; Krishnan, Suneeta ; Nayyar, Anjali ; Swaminathan, Soumya</creatorcontrib><description>India contributed to one-fourth of the global burden of cervical cancer in 2000. [...]researchers emphasized the need for population-based interventions in India to reduce the overall burden of cervical cancer globally[3]. A multidisciplinary Expert Group constituted by the Secretary, Department of Health Research (DHR) and Director-General (DG), Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India, reviewed the available evidence globally regarding immunogenicity and efficacy, adverse effects and cost-effectiveness of the HPV vaccine. HPV infections, precancerous lesions and anogenital warts A systematic review of 20 studies from nine high-income countries analyzed the risk reduction in the HPV infection and anogenital warts in the vaccinated cohorts[9]. Protection is for only selected HPV types and does not cover all high-risk types. [...]comprehensive cervical cancer control also requires cervical cancer screening for early detection and treatment, even for those cohorts vaccinated against HPV.</description><identifier>ISSN: 0971-5916</identifier><identifier>DOI: 10.4103/ijmr.IJMR_1906_16</identifier><identifier>PMID: 29265015</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Cervical cancer ; Cervix Uteri - immunology ; Cervix Uteri - pathology ; Dosage and administration ; Female ; Human papillomavirus ; Humans ; India - epidemiology ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - immunology ; Papillomavirus Infections - prevention & control ; Papillomavirus Infections - virology ; Papillomavirus vaccines ; Papillomavirus Vaccines - adverse effects ; Papillomavirus Vaccines - therapeutic use ; Practice guidelines (Medicine) ; Prevention ; Studies ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - immunology ; Uterine Cervical Neoplasms - prevention & control ; Uterine Cervical Neoplasms - virology ; Vaccination ; Vaccines ; Viewpoint ; Womens health</subject><ispartof>Indian journal of medical research (New Delhi, India : 1994), 2017-08, Vol.146 (2), p.153-157</ispartof><rights>COPYRIGHT 2017 Medknow Publications and Media Pvt. Ltd.</rights><rights>2017. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2017 Indian Journal of Medical Research 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c494t-b159d003a9bd1efcf00675fae05c8f0c43330088f7b02c5fbf6a49aa728ae06b3</citedby><cites>FETCH-LOGICAL-c494t-b159d003a9bd1efcf00675fae05c8f0c43330088f7b02c5fbf6a49aa728ae06b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761024/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761024/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29265015$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaur, Prabhdeep</creatorcontrib><creatorcontrib>Mehrotra, Ravi</creatorcontrib><creatorcontrib>Rengaswamy, Sankaranarayanan</creatorcontrib><creatorcontrib>Kaur, Tanvir</creatorcontrib><creatorcontrib>Hariprasad, Roopa</creatorcontrib><creatorcontrib>Mehendale, Sanjay M</creatorcontrib><creatorcontrib>Rajaraman, Preetha</creatorcontrib><creatorcontrib>Rath, G K</creatorcontrib><creatorcontrib>Bhatla, Neerja</creatorcontrib><creatorcontrib>Krishnan, Suneeta</creatorcontrib><creatorcontrib>Nayyar, Anjali</creatorcontrib><creatorcontrib>Swaminathan, Soumya</creatorcontrib><title>Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India</title><title>Indian journal of medical research (New Delhi, India : 1994)</title><addtitle>Indian J Med Res</addtitle><description>India contributed to one-fourth of the global burden of cervical cancer in 2000. [...]researchers emphasized the need for population-based interventions in India to reduce the overall burden of cervical cancer globally[3]. A multidisciplinary Expert Group constituted by the Secretary, Department of Health Research (DHR) and Director-General (DG), Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India, reviewed the available evidence globally regarding immunogenicity and efficacy, adverse effects and cost-effectiveness of the HPV vaccine. HPV infections, precancerous lesions and anogenital warts A systematic review of 20 studies from nine high-income countries analyzed the risk reduction in the HPV infection and anogenital warts in the vaccinated cohorts[9]. Protection is for only selected HPV types and does not cover all high-risk types. [...]comprehensive cervical cancer control also requires cervical cancer screening for early detection and treatment, even for those cohorts vaccinated against HPV.</description><subject>Cervical cancer</subject><subject>Cervix Uteri - immunology</subject><subject>Cervix Uteri - pathology</subject><subject>Dosage and administration</subject><subject>Female</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>India - epidemiology</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Papillomavirus Infections - immunology</subject><subject>Papillomavirus Infections - prevention & control</subject><subject>Papillomavirus Infections - virology</subject><subject>Papillomavirus vaccines</subject><subject>Papillomavirus Vaccines - adverse effects</subject><subject>Papillomavirus Vaccines - therapeutic use</subject><subject>Practice guidelines (Medicine)</subject><subject>Prevention</subject><subject>Studies</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - immunology</subject><subject>Uterine Cervical Neoplasms - prevention & control</subject><subject>Uterine Cervical Neoplasms - virology</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Viewpoint</subject><subject>Womens health</subject><issn>0971-5916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptUU1v1DAQ9QFES-EHcEGWkLjtMnbiJOaAVFXQLipCquBsTRy7eBXbwd5E5d_j3X7QStiHkd689zQzj5A3DNY1g-qD2_q03nz9dqWYhEax5hk5BtmylZCsOSIvc94CMMlb-YIccckbAUwck3Qxewx0wsmNY_S4uDRnuqDWLhhqY6IagzalmLS4Gzols5iwczF8pFe4rzga-p4mo6P3JgwHLB-Uzk-jKdjugFEX6CYMDl-R5xbHbF7f1RPy88vnH2cXq8vv55uz08uVrmW9W_VMyAGgQtkPzFhtAZpWWDQgdGdB11VVAXSdbXvgWtjeNlhLxJZ3hdP01Qn5dOs7zb03gy6DJBzVlJzH9EdFdOppJ7hf6jouSrQNA14Xg3d3Bin-nk3eqW2cU1k4K85Fx1l57T_WdbmEcsHGYqa9y1qdCg7l1Izzwlr_h1X-YLzTMRjrCv5EwG4FOsWck7EPgzNQ-8TVPnH1OPGieft44wfFfdzVX0h3rP0</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Kaur, Prabhdeep</creator><creator>Mehrotra, Ravi</creator><creator>Rengaswamy, Sankaranarayanan</creator><creator>Kaur, Tanvir</creator><creator>Hariprasad, Roopa</creator><creator>Mehendale, Sanjay M</creator><creator>Rajaraman, Preetha</creator><creator>Rath, G K</creator><creator>Bhatla, Neerja</creator><creator>Krishnan, Suneeta</creator><creator>Nayyar, Anjali</creator><creator>Swaminathan, Soumya</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Scientific Scholar</general><general>Medknow Publications & Media Pvt Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>5PM</scope></search><sort><creationdate>20170801</creationdate><title>Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India</title><author>Kaur, Prabhdeep ; Mehrotra, Ravi ; Rengaswamy, Sankaranarayanan ; Kaur, Tanvir ; Hariprasad, Roopa ; Mehendale, Sanjay M ; Rajaraman, Preetha ; Rath, G K ; Bhatla, Neerja ; Krishnan, Suneeta ; Nayyar, Anjali ; Swaminathan, Soumya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c494t-b159d003a9bd1efcf00675fae05c8f0c43330088f7b02c5fbf6a49aa728ae06b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cervical cancer</topic><topic>Cervix Uteri - immunology</topic><topic>Cervix Uteri - pathology</topic><topic>Dosage and administration</topic><topic>Female</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>India - epidemiology</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Papillomavirus Infections - immunology</topic><topic>Papillomavirus Infections - prevention & control</topic><topic>Papillomavirus Infections - virology</topic><topic>Papillomavirus vaccines</topic><topic>Papillomavirus Vaccines - adverse effects</topic><topic>Papillomavirus Vaccines - therapeutic use</topic><topic>Practice guidelines (Medicine)</topic><topic>Prevention</topic><topic>Studies</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - immunology</topic><topic>Uterine Cervical Neoplasms - prevention & control</topic><topic>Uterine Cervical Neoplasms - virology</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Viewpoint</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaur, Prabhdeep</creatorcontrib><creatorcontrib>Mehrotra, Ravi</creatorcontrib><creatorcontrib>Rengaswamy, Sankaranarayanan</creatorcontrib><creatorcontrib>Kaur, Tanvir</creatorcontrib><creatorcontrib>Hariprasad, Roopa</creatorcontrib><creatorcontrib>Mehendale, Sanjay M</creatorcontrib><creatorcontrib>Rajaraman, Preetha</creatorcontrib><creatorcontrib>Rath, G K</creatorcontrib><creatorcontrib>Bhatla, Neerja</creatorcontrib><creatorcontrib>Krishnan, Suneeta</creatorcontrib><creatorcontrib>Nayyar, Anjali</creatorcontrib><creatorcontrib>Swaminathan, Soumya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of medical research (New Delhi, India : 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaur, Prabhdeep</au><au>Mehrotra, Ravi</au><au>Rengaswamy, Sankaranarayanan</au><au>Kaur, Tanvir</au><au>Hariprasad, Roopa</au><au>Mehendale, Sanjay M</au><au>Rajaraman, Preetha</au><au>Rath, G K</au><au>Bhatla, Neerja</au><au>Krishnan, Suneeta</au><au>Nayyar, Anjali</au><au>Swaminathan, Soumya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India</atitle><jtitle>Indian journal of medical research (New Delhi, India : 1994)</jtitle><addtitle>Indian J Med Res</addtitle><date>2017-08-01</date><risdate>2017</risdate><volume>146</volume><issue>2</issue><spage>153</spage><epage>157</epage><pages>153-157</pages><issn>0971-5916</issn><abstract>India contributed to one-fourth of the global burden of cervical cancer in 2000. [...]researchers emphasized the need for population-based interventions in India to reduce the overall burden of cervical cancer globally[3]. A multidisciplinary Expert Group constituted by the Secretary, Department of Health Research (DHR) and Director-General (DG), Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India, reviewed the available evidence globally regarding immunogenicity and efficacy, adverse effects and cost-effectiveness of the HPV vaccine. HPV infections, precancerous lesions and anogenital warts A systematic review of 20 studies from nine high-income countries analyzed the risk reduction in the HPV infection and anogenital warts in the vaccinated cohorts[9]. Protection is for only selected HPV types and does not cover all high-risk types. [...]comprehensive cervical cancer control also requires cervical cancer screening for early detection and treatment, even for those cohorts vaccinated against HPV.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>29265015</pmid><doi>10.4103/ijmr.IJMR_1906_16</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0971-5916 |
| ispartof | Indian journal of medical research (New Delhi, India : 1994), 2017-08, Vol.146 (2), p.153-157 |
| issn | 0971-5916 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5761024 |
| source | MEDLINE; PubMed Central; PubMed Central Open Access |
| subjects | Cervical cancer Cervix Uteri - immunology Cervix Uteri - pathology Dosage and administration Female Human papillomavirus Humans India - epidemiology Papillomavirus Infections - epidemiology Papillomavirus Infections - immunology Papillomavirus Infections - prevention & control Papillomavirus Infections - virology Papillomavirus vaccines Papillomavirus Vaccines - adverse effects Papillomavirus Vaccines - therapeutic use Practice guidelines (Medicine) Prevention Studies Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - immunology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology Vaccination Vaccines Viewpoint Womens health |
| title | Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A58%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20papillomavirus%20vaccine%20for%20cancer%20cervix%20prevention:%20Rationale%20&%20recommendations%20for%20implementation%20in%20India&rft.jtitle=Indian%20journal%20of%20medical%20research%20(New%20Delhi,%20India%20:%201994)&rft.au=Kaur,%20Prabhdeep&rft.date=2017-08-01&rft.volume=146&rft.issue=2&rft.spage=153&rft.epage=157&rft.pages=153-157&rft.issn=0971-5916&rft_id=info:doi/10.4103/ijmr.IJMR_1906_16&rft_dat=%3Cgale_pubme%3EA520292122%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2258211117&rft_id=info:pmid/29265015&rft_galeid=A520292122&rfr_iscdi=true |